WilliamRMaconMD

PubMed

• 1 citations
  PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
  Sanjal H Desai, Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew Feldma...> ;Blood Cancer Journal. 2022 May 3
• Histiocyte-rich pseudotumor - a post-chemotherapy radiologic dilemma.
  Ravindran, A., Macon, W., Rech, K.> ;Journal of Hematopathology. 2022 Mar 1
• 5 citations
  Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic ...
  Rebecca L. King, Arushi Khurana, Raphael Mwangi, Angelo Fama, Kay M. Ristow, Matthew J. Maurer, William R. Macon, Stephen M. Ansell, N. Nora Bennani, Yogish C. Kudva, ...> ;Hemasphere. 2021 Sep 6
• 2 citations
  Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from fol...
  Sanjal Desai, Betsy LaPlant, William R. Macon, Rebecca L. King, Yucai Wang, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansel...> ;Blood Cancer Journal. 2021 Sep 25
• 8 citations
  Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
  Robert M. Kraft, Stephen M. Ansell, Jose C. Villasboas, N. Nora Bennani, Yucai Wang, Thomas M. Habermann, Gita Thanarajasingam, Scott C. Lester, William R. Macon, Davi...> ;Hematological Oncology. 2021 Aug 28
• 3 citations
  Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
  Arushi Khurana, Raphael Mwangi, Stephen M. Ansell, Thomas M. Habermann, James R. Cerhan, Christopher Strouse, Brian K. Link, Yucai Wang, Rebecca L. King, William R. Ma...> ;Blood Cancer Journal. 2021 Jul 17
• SARS-CoV-2/COVID-19 pandemic produces a new paradigm for international hematopathology meetings.
  William R. Macon> ;Journal of Hematopathology. 2021 May 17
• 4 citations
  Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma.
  Mark Liebow, Melissa C. Larson, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call, William R. Macon, Neil E. Kay, Thomas M. Habermann, Susan L. Slager, James...> ;International Journal of Cancer. 2021 Mar 8
• 46 citations
  Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412
  Grzegorz S. Nowakowski, Fangxin Hong, David Scott, William R. Macon, Rebecca L. King, Thomas M. Habermann, Nina D. Wagner-Johnston, Carla Casulo, James L. Wade, Gauri ...> ;Journal of Clinical Oncology. 2021 Feb 8
• 13 citations
  Analysis and impact of a multidisciplinary lymphoma virtual tumor board
  Thomas M. Habermann, Arushi Khurana, Ruth A Lentz, John J. Schmitz, Alexander G. von Bormann, Jason R. Young, Christopher H. Hunt, Sara N. Christofferson, Grzegorz S. ...> ;Leukemia & Lymphoma. 2020 Sep 23
• 2 citations
  Bone involvement on PET/CT predicts event-free survival in follicular lymphoma Grade 3B.
  Frederique St-Pierre, Stephen M. Broski, Betsy LaPlant, Kay M. Ristow, William R. Macon, Thomas M. Habermann, Thomas E. Witzig> ;British Journal of Haematology. 2020 Jul 23
• 2 citations
  COVID-19 and remembering Professor Dennis H. Wright.
  William R. Macon> ;Journal of Hematopathology. 2020 May 26
• 3 citations
  Hypomagnesemia is associated with an increased risk of early clinical failure in patients with Burkitt lymphoma.
  Jennifer Gile, Gordon Ruan, Jithma P. Abeykoon, M. Molly McMahon, William R. Macon, Thomas E. Witzig> ;Leukemia & Lymphoma. 2020 May 2
• 6 citations
  Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
  Frederique St-Pierre, Stephen M. Broski, Betsy LaPlant, Matthew J. Maurer, Kay M. Ristow, Gita Thanarajasingam, William R. Macon, Thomas M. Habermann, Thomas E. Witzig> ;The Oncologist. 2020 Aug 1
• 24 citations
  Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
  Keenan T. Hartert, Kerstin Wenzl, Jordan E. Krull, Michelle K. Manske, Vivekananda Sarangi, Yan W. Asmann, Melissa C. Larson, Matthew J. Maurer, Susan L. Slager, Willi...> ;Leukemia. 2021 Feb 1
• 1 citations
  HISTOLOGIC FINDINGS IN VITREORETINAL LYMPHOMA: Learning From Enucleation Specimens.
  Sam T Albadri, Jose S Pulido, William R Macon, Joaquin J Garcia, Diva R Salomao> ;Retina. 2020 Feb 1
• 6 citations
  Is the Time Right to Start Using Digital Pathology and Artificial Intelligence for the Diagnosis of Lymphoma
  Mohamed E. Salama, William R. Macon, Liron Pantanowitz> ;Journal of Pathology Informatics. 2020 Jan 1
• HISTOLOGIC FINDINGS IN VITREORETINAL LYMPHOMA: Learning From Enucleation Specimens.
  Albadri, S. T., Pulido, J. S., Macon, W. R., Garcia, J. J., Salomao, D. R.> ;Retina (Philadelphia, Pa.). 2019 Oct 16
• 14 citations
  Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor.
  Melissa M. Blessing, Patrick R. Blackburn, Chandra Krishnan, Virginia L. Harrod, Emily G. Barr Fritcher, Christopher D. Zysk, Rory A. Jackson, Dragana Milosevic, Asha ...> ;Journal of Neuropathology and Experimental Neurology. 2019 Nov 1
• 5 citations
  Combined Tumors in Hematolymphoid Neoplasms: Case Series of Histiocytic and Langerhans Cell Sarcomas Arising From Low-Grade B-Cell Lymphoma.
  Stephanie L. Skala, Jing C Ye, Jennifer Stumph, William R. Macon, Frances R Quinones, Vadim Khachaturov, Rhett P. Ketterling, Rajan Dewar> ;Clinical Pathology. 2019 Sep 29
• 13 citations
  Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma.
  Frederique St-Pierre, Stephen M. Broski, Betsy LaPlant, Kay M. Ristow, Matthew J. Maurer, William R. Macon, Thomas M. Habermann, Stephen M. Ansell, Carrie A. Thompson,...> ;American Journal of Hematology. 2019 Jul 1
• 13 citations
  Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma ...
  Jess F. Peterson, Beth A. Pitel, Stephanie A. Smoley, George Vasmatzis, James B. Smadbeck, Patricia T. Greipp, Rhett P. Ketterling, William R. Macon, Linda B. Baughn> ;Cold Spring Harbor Molecular Case Studies. 2019 Jun 1
• 32 citations
  Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018
  Alessia Castellino, Jose S. Pulido, Patrick B. Johnston, Kay M. Ristow, N. Nora Bennani, David J. Inwards, William R. Macon, Ivana N. Micallef, Rebecca L. King, Diva R...> ;American Journal of Hematology. 2019 Mar 1
• 18 citations
  Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome
  Matthew Walters, Mark R. Pittelkow, Robert P. Hasserjian, Nancy L. Harris, William R. Macon, Paul J. Kurtin, Karen L. Rech> ;The American Journal of Surgical Pathology. 2018 Dec 1
• 28 citations
  Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
  Alessia Castellino, Annalisa Chiappella, Betsy LaPlant, Levy D. Pederson, Gianluca Gaidano, William R. Macon, Giorgio Inghirami, Craig B. Reeder, Alessandra Tucci, Reb...> ;Blood Cancer Journal. 2018 Nov 8
• Join now to see all

Abstracts/Posters

• Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies
  William R. Macon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  William R. Macon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018